Categories AlphaGraphs, Earnings, Health Care
Vertex Pharmaceuticals (VRTX) reports Q1 2020 earnings results
Revised full-year product revenue guidance
Vertex Pharmaceuticals (Nasdaq: VRTX) today reported first quarter financial results for the period ended March 31, 2020.
On GAAP basis, first quarter EPS was $2.29 vs. $1.03 in the first quarter of 2019. Non-GAAP EPS was $2.56, compared to $1.14 in the first quarter of 2019.
Total revenues increased 76% to $1.51 billion.
You may also like:
Most Popular
CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%
Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss
Key metrics from Nike’s (NKE) Q2 2025 earnings results
NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net
FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips
Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,